MRI Medical announces name change to Xeridiem Medical Devices

MRI Medical Inc. is changing its name to Xeridiem Medical Devices, Inc. as part of its corporate development plan.

"Although we're changing our name, we will continue to provide our customers with the same superior design, development, and manufacturing services that we've provided for nearly 30 years," stated Joseph Lee, Xeridiem Medical Devices, Inc.'s President. "Our mission remains the same - to improve healthcare by helping our customers efficiently supply world class medical devices to patients around the world."

Xeridiem Medical Devices, Inc. custom engineers performance-critical, minimally invasive medical devices used in urology, cardiology, gastroenterology, minimally invasive surgery, and gynecology for both major companies and individual entrepreneurs.

"We apply our keen insight and experience to solving our customers' toughest challenges in design and development through validation, testing and documentation for regulatory approval," stated Joseph Lee, President. "Our acquisition in July by Fenner plc gives us access to a deep pool of technical and financial resources to use in launching our customers' products quickly and efficiently. These are exciting developments for Xeridiem Medical Devices, Inc."

SOURCE Xeridiem Medical Devices, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
VANCE trial marks milestone in t cell therapy for solid tumors